GlaxoSmithKline wins Zantac cancer trial, no link found between drug and colorectal cancer.

GlaxoSmithKline (GSK) wins another trial against claims that their discontinued heartburn drug, Zantac, caused cancer. An Illinois woman's colorectal cancer was not found to be linked with Zantac, which contains carcinogenic contaminant NDMA. Thousands of lawsuits against GSK and other manufacturers persist in US courts. The US FDA asked manufacturers to remove Zantac from the market in 2020 due to NDMA concerns.

August 05, 2024
4 Articles